Thinking of joining a study?

Register your interest

NCT06722092 | NOT YET RECRUITING | Aphasia, Acquired


VR and Scrip Training of PWA, Randomized Controlled Trial
Sponsor:

The Hong Kong Polytechnic University

Brief Summary:

The goal of this RCT is to investigate if computerized script training may promote functional communication and nonverbal cognitive functions of Cantonese-speaking PWA, and whether VR may further magnify the treatment outcomes. The main research questions are: 1. Can script training promote verbal functional communication of Cantonese-speaking PWA? 2. Can script training enhance nonverbal cognitive functions of Cantonese-speaking PWA? 3. Can VR magnify verbal and nonverbal treatment outcomes of script training of PWA?

Condition or disease

Aphasia, Acquired

Chronic Stroke

Intervention/treatment

VR-based script training

Conventional script training

Phase

NA

Study Type : INTERVENTIONAL
Estimated Enrollment : 105 participants
Masking : SINGLE
Primary Purpose : TREATMENT
Official Title : Can Immersive Virtual Reality Magnify Treatment Outcomes of Script Training on Cantonese Speakers with Chronic Aphasia: a Randomized Controlled Trial
Actual Study Start Date : 2025-06
Estimated Primary Completion Date : 2027-12
Estimated Study Completion Date : 2028-06

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 30 Years to 80 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • 1. a stroke onset more than six months, with an Aphasia Quotient (AQ) below 96.4, as evaluated by the Cantonese version of Western Aphasia Battery (CAB; Yiu, 1992),
  • 2. premorbid fluent Cantonese speakers,
  • 3. aged between 30 and 80 years,
  • 4. no reported progressive neurogenic disorders such as dementia or Parkinson's disease,
  • 5. no motor speech disorders of moderate to severe level, and
  • 6. normal or corrected-to-normal vision and hearing functions
Exclusion Criteria
  • 1. concurrent participation in other aphasia treatment trials, and
  • 2. incompatibility with immersive VR exposure such as complains of nausea, headache, or other severe discomforts during trial use of a head-mounted device during screening.

VR and Scrip Training of PWA, Randomized Controlled Trial

Location Details

NCT06722092


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


No Location Found

Loading...